1797 – Vibration-Controlled Transient Elastography (VCTE™) for identifying advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Pre-assessment
  • Type New application
  • Pre-PASC consultation Open
  • Pre-MSAC consultation -
  • Outcome Pending

Application details

Applicant

Health Technology Analysts Pty Limited

Reason for application

Service or technology in this application

Vibration Controlled Transient Elastography (VCTE™), is a non-invasive diagnostic tool that assesses the extent of liver fibrosis. VCTE™ works by generating a mechanical pulse that creates a shear wave through the liver tissue. This measurement is converted into a numerical value expressed in kilopascals (kPa), known as the Liver Stiffness Measurement (LSM).

Type: Investigative

Medical condition this application addresses

Metabolic dysfunction-associated fatty liver disease(MAFLD) is a prevalent condition characterised by excessive fat accumulation in the liver due to metabolic dysregulation. It requires hepatic steatosis (fatty liver) along with at least one of the following: overweight/obesity, T2D, or metabolic dysfunction (defined by specific clinical and biochemical criteria). As fat continues to accumulate, MAFLD can progress from simple steatosis to steatohepatitis, characterised by inflammation and liver cell damage. Persistent inflammation and liver cell damage can lead to the activation of hepatic stellate cells, which produce excess extracellular matrix proteins, resulting in fibrosis. Liver fibrosis is staged by its severity on a scale from zero (no fibrosis) to one (mild fibrosis), two (significant fibrosis), three (advanced fibrosis, AF) and four (cirrhosis).

Application documents

Application summary

PICO set 1

PICO set 2

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Consultation survey and deadlines

The following consultation deadlines apply:

  • Pre-PASC consultation deadline: 14 March 2025
  • Pre-MSAC consultation deadline: -

For other ways to provide input, see how to have your say.

We welcome input from everyone. We are especially keen to hear from those with lived experience of the health condition, service or technology the applications are addressing.

Find out more about consultation.

Meetings to consider this application

This application will be considered at the following meetings:

  • PASC meeting: 16 to 17 April 2025
  • ESC meeting: -
  • MSAC meeting: -

Find out more about our meetings.

Outcome details

The outcome of this application is pending.

More information